Brought to you by 
Micrus Endovascular to get technology rights from ReVasc
28 Jun 2021
Executive Summary
Micrus Endovascular (implants and devices for cerebral vascular conditions) has signed a letter of intent to acquire rights to an ischemic stroke treatment technology from ReVasc.
Deal Industry
- Medical Devices
Deal Status
- Preliminary
Deal Type
-
Alliance
- Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com